Furthermore, LRG1, which is activated by the inflammatory IL-6/STAT3 pathway, is significantly elevated in participants with LC and possibly contributes to vascular pathology in LC (55–57). This evidence concerns the gene IL6 and laryngotracheoesophageal cleft.